MIAMI BEACH, Fla., April 20, 2011 /PRNewswire/ -- In its first full year as a public company, 2010, the biotechnology developer Divine Skin Inc. (DSKX) grew annual revenue by 55 percent over 2009 and grew Q4 revenue by 88 percent over the previous Q4, according to audited figures released today.
Annual sales reached $5.4 million, up by $1.9 million over the previous year. Fourth-quarter sales grew to $1.6 million, up by $800,000 from the same quarter of 2009.
The maker of topical treatments for hair and skin experienced rapid growth in its consumer brands, including flagship DS Laboratories and specialty lines Sigma Skin and Polaris Research Laboratories. In 2010 the company launched a premium organic line, The Pure Guild.
Divine Skin advanced significantly its technology platform for new therapies and expanded its consumer health-care division, both of which are expected to generate significant revenue once commercialized.
In his year-end letter to investors, CEO Daniel Khesin cited three major events that contributed to the recent successes:
"Despite the tremendous growth that we witnessed in 2010, we have just scratched the surface," predicted Khesin. "Divine Skin has made several strategic investments over the past year to ensure continued growth throughout the coming months and years." The actions included:
|SOURCE Divine Skin Inc.|
Copyright©2010 PR Newswire.
All rights reserved